BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26858930)

  • 1. Comparison of activity to stimulate mucosal IgA production between Leuconostoc mesenteroides strain NTM048 and type strain JCM6124 in mice.
    Matsuzaki C; Matsumoto K; Katoh T; Yamamoto K; Hisa K
    Biosci Microbiota Food Health; 2016; 35(1):51-5. PubMed ID: 26858930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exopolysaccharides Produced by Leuconostoc mesenteroides Strain NTM048 as an Immunostimulant To Enhance the Mucosal Barrier and Influence the Systemic Immune Response.
    Matsuzaki C; Hayakawa A; Matsumoto K; Katoh T; Yamamoto K; Hisa K
    J Agric Food Chem; 2015 Aug; 63(31):7009-15. PubMed ID: 26207929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulating activity of exopolysaccharide-producing Leuconostoc mesenteroides strain NTM048 from green peas.
    Matsuzaki C; Kamishima K; Matsumoto K; Koga H; Katayama T; Yamamoto K; Hisa K
    J Appl Microbiol; 2014 Apr; 116(4):980-9. PubMed ID: 24314091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatically synthesized exopolysaccharide of a probiotic strain
    Matsuzaki C; Nakashima Y; Endo I; Tomabechi Y; Higashimura Y; Itonori S; Hosomi K; Kunisawa J; Yamamoto K; Hisa K
    Gut Microbes; 2021; 13(1):1949097. PubMed ID: 34288820
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemical Synthesis and Evaluation of Exopolysaccharide Fragments Produced by Leuconostoc mesenteroides Strain NTM048.
    Inuki S; Tabuchi H; Matsuzaki C; Yonejima Y; Hisa K; Kimura I; Yamamoto K; Ohno H
    Chem Pharm Bull (Tokyo); 2022; 70(2):155-161. PubMed ID: 35110436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chocolate containing
    Kuroda R; Higuchi H; Yoshida K; Yonejima Y; Hisa K; Utsuyama M; Osawa K; Hirokawa K
    Immun Ageing; 2018; 15():29. PubMed ID: 30479641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levansucrase from Leuconostoc mesenteroides NTM048 produces a levan exopolysaccharide with immunomodulating activity.
    Ishida R; Sakaguchi K; Matsuzaki C; Katoh T; Ishida N; Yamamoto K; Hisa K
    Biotechnol Lett; 2016 Apr; 38(4):681-7. PubMed ID: 26960415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural characterization of the immunostimulatory exopolysaccharide produced by Leuconostoc mesenteroides strain NTM048.
    Matsuzaki C; Takagaki C; Tomabechi Y; Forsberg LS; Heiss C; Azadi P; Matsumoto K; Katoh T; Hosomi K; Kunisawa J; Yamamoto K; Hisa K
    Carbohydr Res; 2017 Aug; 448():95-102. PubMed ID: 28633071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leuconostoc mesenteroides subsp. strain NTM048 ameliorated nasal symptoms in patients with Japan cedar pollinosis: Randomized, double-blind, and placebo-controlled trial.
    Yamamoto Y; Sugita G; Hiraoka M; Takagi S; Yamagishi N; Kawashima S; Tanioka K; Nishi T; Yamamoto S; Kakutani C; Yanase A; Kanai Y; Kato S; Hotomi M
    Medicine (Baltimore); 2023 Nov; 102(45):e35343. PubMed ID: 37960817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunostimulatory effect on dendritic cells of the adjuvant-active exopolysaccharide from Leuconostoc mesenteroides strain NTM048.
    Matsuzaki C; Takagaki C; Higashimura Y; Nakashima Y; Hosomi K; Kunisawa J; Yamamoto K; Hisa K
    Biosci Biotechnol Biochem; 2018 Sep; 82(9):1647-1651. PubMed ID: 29863431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supplemental Leuconostoc mesenteroides strain NTM048 attenuates imiquimod-induced psoriasis in mice.
    Ogawa C; Inoue R; Yonejima Y; Hisa K; Yamamoto Y; Suzuki T
    J Appl Microbiol; 2021 Dec; 131(6):3043-3055. PubMed ID: 34028144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated membrane IgA+ and CD4+ (T helper) populations in murine Peyer's patch and splenic lymphocytes during dietary administration of the trichothecene vomitoxin (deoxynivalenol).
    Pestka JJ; Dong W; Warner RL; Rasooly L; Bondy GS; Brooks KH
    Food Chem Toxicol; 1990 Jun; 28(6):409-20. PubMed ID: 2145206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternate mucosal immune system: organized Peyer's patches are not required for IgA responses in the gastrointestinal tract.
    Yamamoto M; Rennert P; McGhee JR; Kweon MN; Yamamoto S; Dohi T; Otake S; Bluethmann H; Fujihashi K; Kiyono H
    J Immunol; 2000 May; 164(10):5184-91. PubMed ID: 10799877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria.
    Perdigón G; Vintiñi E; Alvarez S; Medina M; Medici M
    J Dairy Sci; 1999 Jun; 82(6):1108-14. PubMed ID: 10386296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic in vivo depletion of CD4 T cells begun in utero inhibits gut B cell differentiation.
    Tolaymat N; Weber SP; Cowdery JS
    Clin Immunol Immunopathol; 1990 Jul; 56(1):97-107. PubMed ID: 1972673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.
    Elson CO; Ealding W
    J Immunol; 1984 Jun; 132(6):2736-41. PubMed ID: 6233359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of T cell and B cell function in Peyer's patch and lamina propria of New Zealand Black and DBA/2 mice.
    Cowdery JS; McKiernan FE
    J Immunol; 1986 Jun; 136(11):4070-4. PubMed ID: 3486225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of IgA B cell differentiation of bone marrow-derived B cells by Peyer's patch autoreactive helper T cells.
    Kihira T; Kawanishi H
    Immunol Invest; 1995 Aug; 24(5):701-11. PubMed ID: 8543335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactic Acid Bacteria Improves Peyer's Patch Cell-Mediated Immunoglobulin A and Tight-Junction Expression in a Destructed Gut Microbial Environment.
    Kim SH; Jeung W; Choi ID; Jeong JW; Lee DE; Huh CS; Kim GB; Hong SS; Shim JJ; Lee JL; Sim JH; Ahn YT
    J Microbiol Biotechnol; 2016 Jun; 26(6):1035-45. PubMed ID: 26975767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the administration of Lactobacillus paracasei subsp. paracasei NTU 101 on Peyer's patch-mediated mucosal immunity.
    Tsai YT; Cheng PC; Liao JW; Pan TM
    Int Immunopharmacol; 2010 Jul; 10(7):791-8. PubMed ID: 20417727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.